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Abstract Chondromodulin-I (ChM-I) is an angiogenesis inhi-
bitor isolated from fetal bovine cartilage. Here, we report the
nucleotide sequence of chicken ChM-I cDNA. Chicken mature
ChM-I had a significantly larger N-terminal hydrophilic domain
than its mammalian counterparts. Chicken embryos expressed
multiple transcripts (3.3, 2.0 and 1.7 kb in size) due to the
alternative utilization of polyadenylation signals, whereas only
the 1.7 kb transcripts were detected in mammals. Although
confined to cartilage and eye at a later stage of development,
whole-mount in situ hybridization revealed the expression of
ChM-I mRNA in somites, heart, bronchial arches, roof plate,
retina and limb buds. The expression pattern of the gene suggests
a role for ChM-I in the morphogenesis during embryonic
development.
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1. Introduction
Chondromodulin-I (ChM-I) is a 25 kDa glycoprotein orig-
inally puri¢ed from bovine epiphyseal cartilage on the basis of
its growth-promoting activity for cultured chondrocytes [1].
Proteoglycan synthesis in growth plate chondrocytes and col-
ony formation of chondrocytes in agarose culture were stimu-
lated by ChM-I [2]. ChM-I also stimulated the growth of
osteoblasts in vitro [3]. Recently, we demonstrated that
ChM-I inhibits the growth of cultured vascular endothelial
cells in vitro, as well as angiogenesis in vivo [4^6]. During
skeletogenesis, the expression of ChM-I mRNA was restricted
to the avascular zone of cartilage in the developing bone rudi-
ments [4,7]. The level of ChM-I mRNA in primary chondro-
cytes was regulated by a variety of local growth factors [8].
When added to de-mineralized bone matrix, exogenous ChM-
I protein inhibited the replacement of cartilage by bone in
vivo [7]. These previous observations indicate that ChM-I
plays a regulatory role in the bone formation.
Interestingly, we recently found that mouse embryos ex-
pressed the ChM-I transcripts at a high level even in the stages
prior to cartilage formation [7], implying that the gene plays a
role in the early embryonic development. Chicken embryos
are more amenable to developmental analysis and manipula-
tion in comparison with mice. In the present study, we deter-
mined the nucleotide sequence of chicken ChM-I cDNA iso-
lated from the day 10 chicken embryo cDNA library. The
cDNA was used as a hybridization probe for Northern blot
and in situ hybridization analysis. In addition to the 1.7 kb
transcripts [1,7,8], we found that the larger transcripts for
ChM-I (3.3 and 2.0 kb in size) were expressed in the avian
tissues due to the multiple polyadenylation signals in the 3P-
untranslated region of the gene. Moreover, the gene was evi-
dently expressed in association with a variety of embryonic
structures prior to cartilage formation.
2. Material and methods
2.1. Rapid ampli¢cation of cDNA ends (RACE)
According to the manufacturer’s instructions, the RACE was per-
formed using the 3P-RACE system (Gibco BRL, Gaithersburg, MD,
USA). First-strand cDNA was generated using the adapter primer
that was oligo(dT)-engineered. Aliquots of 1/20 of the cDNA were
used as a template for the ampli¢cation with the anchor primer com-
plementary to the speci¢c 5P-sequence of the adapter primer and the
primer P1 (5P-CATCGGGGCCTTCTACTTCT-3P) that was designed
on the basis of the conserved sequence between human and bovine
ChM-I cDNA [1,6]. For the 3P-RACE of the longest transcript, cDNA
was ampli¢ed using the nested anchor primer and the primer P2 (5P-
GACAACCTCATGCAGAATGC-3P) that was nested downstream of
the primer P3 (5P-CTACGGAAGGTACTGAGCTGAAG-3P). The
ampli¢ed PCR products were subcloned into pCRII (Invitrogen,
San Diego, CA, USA). For 5P-RACE, adapter-ligated double-
stranded cDNAs were prepared using a Marathon cDNA Ampli¢ca-
tion kit (Clontech, Palo Alto, CA, USA) according to the manufac-
turer’s instructions. The cDNA was ampli¢ed using an anchor primer
and the primer P3 (5P-CGGTGATGCCAATCTGGAAATC-3P). The
ampli¢ed PCR products were subcloned into pCRII.
2.2. Screening of the day 10 chicken embryo Vgt11 cDNA library
A Vgt11 cDNA library constructed from whole day 10 white leg-
horn embryos was purchased from Clontech for isolation of chicken
ChM-I cDNA clones. A total of 5U105 independent recombinant
phages was initially screened with a partial cDNA clone (RCI1) ob-
tained from the 3P-RACE. The hybridization-positive clones were iso-
lated by the repeated plaque puri¢cation. The inserts isolated from the
phage clones were subcloned into the EcoRI site of pBluescript II
SK(+) (Stratagene, La Jolla, CA, USA). The nucleotide sequence of
the inserts was determined using the Big Dye Terminator Cycle Se-
quencing FS Ready Reaction kit with ABI 310 Genetic Analyzer
(Applied Biosystems, Foster City, CA, USA). Both cDNA strands
were sequenced using the standard sequencing primers and gene-spe-
ci¢c primers. The obtained DNA sequences were compiled and ana-
lyzed by GeneWorks computer programs (IntelliGenetics, Tokyo, Ja-
pan).
2.3. Northern hybridization
Total RNA was prepared from sterna of chicken day 20 embryos
by a single step method, according to Chomczynski and Sacchi [9].
For Northern blot analysis, 20 Wg of the total RNA was denatured
with 6% formaldehyde, fractionated by 1% agarose gel (SeaKem
GTG, FMC Bioproducts, Rockland, ME, USA) electrophoresis and
transferred onto Nytran membranes (Schleicher and Schuell, Dassel,
Germany) with Turboblotter (Schleicher and Schuell). Hybridization
was performed overnight at 42‡C with an appropriate cDNA probe
labelled with [K-32P]dCTP (106 cpm/ml) in a solution containing 50%
formamide, 6USSPE (0.9 M NaCl, 20 mM NaH2PO4, 6 mM EDTA
at pH 7.4), 0.1% bovine serum albumin (Calbiochem-Novabiochem,
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La Jolla, CA, USA), 0.1% Ficoll 400 (Pharmacia, Sweden), 0.1%
polyvinylpyrrolidone (Wako Pure Chemical, Osaka, Japan), 0.5%
SDS and 100 Wg/ml denatured salmon sperm DNA. The cDNA
probes were labelled with a [K-32P]dCTP (Amersham, UK) by the
random-primer method using a BcaBEST labelling kit (Takara, Otu,
Japan) using the appropriate cDNA fragments: the 1.0 kb EcoRI
fragment of RCI1, the 0.35 kb fragment ampli¢ed from RCI1 (probe
A) and the 0.8 kb fragment ampli¢ed from LCI33-2-3 (probe B), as
the probes for ChM-I mRNA. The 1.15 kb BamHI-PvuII fragment of
pYN509 was used as a probe for chicken type II collagen [10]. After
hybridization, ¢lters were washed for 30 min at 55‡C in 2USSPE,
0.1% SDS, then washed for 30 min at 55‡C in 0.1USSPE, 0.1%
SDS and exposed to BIOMAX ¢lm (Eastman Kodak, Rochester,
NY, USA) at 380‡C.
2.4. In situ hybridization
Chicken embryos were obtained by incubation of fertilized white
leghorn eggs and staged according to Hamburger and Hamilton [11].
For whole-mount in situ hybridization, the antisense and sense cRNA
probes were transcribed from RCI1 with a DIG RNA labelling kit
(Boehringer Mannheim, Mannheim, Germany). Chicken embryos
were ¢xed in 4% paraformaldehyde (PFA) resolved in phosphate-bu¡-
ered saline (PBS) and gradually transferred into methanol by ex-
change of the PFA/PBS against the increasing concentrations of meth-
anol/PBS. After rehydration, the embryos were incubated with the
antisense cRNA probes. Hybridization was performed at 70‡C over-
night and the embryos were washed under conditions of high strin-
gency. Hybridization was detected immunohistochemically by an al-
kaline phosphatase-conjugated antibody to obtain purple deposits at
the site of hybridization using a nucleic acid detection kit (Boehringer
Mannheim). Appropriate control experiments were performed to ex-
clude false-positive staining due to the endogenous alkaline phospha-
tase activity and they were negative.
3. Results and discussion
To isolate the chicken ChM-I cDNA, we extracted total
RNA from sternum of stage 45 (day 19) chicken embryos
and performed 3P-RACE by anchor primer and the primer
P1 designed on the basis of the nucleotide sequence conserved
between bovine and human [1,6]. One clone (RCI1) encoded
3/4 of the coding region and the 3P-untranslated region includ-
ing the polyadenylation signal (AATAAA) followed by a
poly(A)-tail (Fig. 1A). Using this clone as a probe, we
screened the day 10 chicken embryo Vgt11 cDNA library.
30 Positive clones were identi¢ed from 3U105 recombinant
phage clones. Six clones were randomly selected for puri¢ca-
tion and subcloning for further analysis (Fig. 1A). Since all
the clones obtained from the cDNA library lacked the 5P-
region of the cDNA, we performed 5P-RACE and obtained
the clone containing the initial codon.
Three clones (LCI1-3, LCI10-6 and LCI33-2-3) contained
approximately 1.6 kb of the 3P-untranslated region with three
polyadenylation signals (AATAAA) (Fig. 1A). In addition to
that at position 1196 (PA1), a signal was present at position
1466 (PA2) and at position 2362 (PA3), respectively. One
clone (LCI2-1) is the short form containing only PA1 fol-
lowed by a poly(A)-tail. The position of the polyadenylation
signal is identical to that of clone RCI1. Clone LCI5-1 con-
tained one polyadenylation signal at the same position but
lacked the poly(A)-tail. Clone LCI8-1 contained two polyade-
nylation signals without a poly(A)-tail. Three clones (LCI1-3,
LCI10-6 and LCI33-2-3) contained the 3P-untranslated re-
gions (approximately 1.6 kb in size) with three polyadenyla-
tion signals. We performed the 3P-RACE experiment to deter-
mine if there was any additional 3P-untranslated sequence.
The 3P-RACE provided an additional downstream sequence
of approximately 70 bases, but no additional polyadenylation
signal was found (Fig. 1A).
Nucleotide and deduced amino acid sequences of chicken
ChM-I cDNA were assembled (Fig. 1B). Chicken ChM-I
cDNA contained a 1041 bp open reading frame harboring
347 amino acid residues for ChM-I precursor protein. Initial
and terminal codons were found at positions 3 and 1044,
respectively. The nucleotide sequence in the coding region
was 72% identical with that of the bovine counterpart. The
mature ChM-I sequence was preceded by a processing signal
(RERR), which was completely conserved between chicken
Fig. 1. Molecular cloning of the chicken ChM-I cDNA. (A) Cloning strategy. The top bar depicts the structure of chicken ChM-I cDNA. The
part of the cDNA corresponding to the coding region is represented by a box. The polyadenylation sites (AATAAA) are marked by arrow-
heads. The primer P1, which is designed on the basis of the nucleotide sequences conserved between bovine and human, was used for 3P-
RACE of the short form transcripts. The cDNA clones (LCI1-3, LCI2-1, LCI5-1, LCI8-1, LCI10-6 and LCI33-2-3), which were obtained from
the chicken day 10 embryo library by using RCI1 as a probe, are shown below. The 3P-end of the nucleotide sequence derived from the longest
transcripts was ampli¢ed by 3P-RACE. The 5P-end of the cDNA was obtained by 5P-RACE. (B) Nucleotide sequence of chicken ChM-I cDNA
with the deduced amino acid sequence. The nucleotide sequence is given to the left and the right sides of each line. The putative transmem-
brane domain is underlined and the putative processing signal is double-underlined. The mature portion of the deduced amino acids is boxed.
The asterisks indicate the potential N-linked glycosylation site. Cysteine residues are encircled. The consensus sequence of polyadenylation sites
(AATAAA) is indicated in bold and the poly(A)-tail is given. This sequence has been deposited in the GenBank database under accession num-
ber AF027380.
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and other mammalian homologues (Fig. 2) [1,6^8]. The pos-
sible transmembrane domain in the precursor was also con-
served. Most amino acid substitutions and insertions were
found in the N-terminal hydrophilic domain of the mature
ChM-I (Fig. 2). However, the N-glycosylation site (NXT) in
this domain was conserved among all of the cloned homo-
logues (Fig. 2). In contrast to the N-terminal domain, the
C-terminal 2/3 of the mature ChM-I was well conserved be-
Fig. 1 (continued).
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tween the species, including all eight Cys residues in this do-
main (Fig. 2).
In mammals, the 1.7 kb transcript was predominantly ex-
pressed in cartilage [1,7,8]. However, three possible polyade-
nylation signals were found within the 3P-untranslated region
of chicken ChM-I cDNA (Fig. 1B), whereas other mammalian
cDNAs have only one. Consistent with this ¢nding, Northern
blotting with probe A, covering a portion of the coding se-
quence, revealed three transcripts with approximate sizes of
1.7, 2.0 and 3.3 kb in day 20 chicken sternal cartilage (Fig.
3A). Probe B containing the downstream polyadenylation sig-
nal PA3 detected only the 3.3 kb transcripts (Fig. 3A), sug-
gesting that the multiple ChM-I transcripts in chicken carti-
lage were generated by the alternative utilization of
polyadenylation signals in the 3P-untranslated region. As in
mammalian tissues [1,7], the ChM-I gene was expressed in a
tissue-speci¢c manner in cartilage and eye in the Northern
blot analysis of stage 45 (day 20) chicken embryos (Fig.
3B). In both tissues, the major transcripts were those of 3.3
kb in size, but all three transcripts were detected. We did not
detect the expression of ChM-I mRNA in liver, heart, intes-
tine or brain at this stage of development (Fig. 3B).
In the developing cartilaginous bone rudiments of chicken
embryos at stage 41 (day 15), ChM-I transcripts were present
in the avascular zone of cartilage, but absent in the late-hyper-
trophic and calci¢ed zone (data not shown), consistent with
previous observations in mammals [4,7]. The expression of the
ChM-I gene was augmented in a manner dependent on chon-
drogenic di¡erentiation and was abolished upon the applica-
tion of de-di¡erentiation signals to chondrocytes, such as by
treatment with parathyroid hormone or parathyroid hor-
mone-related peptide [7,8]. Recently, chicken ChM-I cDNA
was identi¢ed as a cartilage-speci¢c gene markedly down-
regulated by retinoic acid (U. Dietz, personal communication,
GSF-Research Center, Munich, Germany). Retinoic acid
causes a rapid de-di¡erentiation of chondrocytes in vitro
[12]. Taken together, the expression of the ChM-I gene was
closely associated with acquiring the mature phenotype of
cartilage that exhibited a powerful anti-angiogenic property.
Northern blot analysis revealed that the expression of the
ChM-I gene is restricted to cartilage and eye at the later stage
of development (Fig. 3A). However, whole-mount in situ hy-
bridization clearly indicated that ChM-I was expressed at the
stages of development preceding cartilage formation in chick-
en embryos (Fig. 4). We detected the expression of ChM-I
mRNA in various non-cartilaginous structures such as so-
mites, limb buds, bronchial arches, heart, eye and roof plate
of neural tube. The pattern of expression suggested that ChM-
I plays a role in morphogenesis during the early development
of embryos. The pattern of expression in limb buds was of
most interest in the light of vascular development prior to
cartilage formation. Limb bud development begins when mes-
enchymal cells proliferate from the somitic layer of the limb
¢eld lateral plate mesoderm around stage 17 [13]. In associa-
tion with the limb bud outgrowth, the vascular system is de-
veloped by the sprouting angiogenesis from the aorta. How-
ever, an avascular peripheral zone of mesoderm remains
beneath the apical ectodermal ridge [13]. The expression of
Fig. 2. Amino acid sequence comparison of chick mature ChM-I with those of mammalian species. Conserved amino acid residues are under-
lined. Positions of Cys residues and the potential N-linked glycosylation site are denoted by (*) and (2), respectively.
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ChM-I mRNA was ¢rst recognized in this avascular zone in
limb buds at stage 21 (Fig. 4), whereas no limb expression of
ChM-I mRNA was detected at stage 19 (data not shown).
Then, the ChM-I expression was detected at the center of
limb buds (Fig. 4, inset) when vascular regression took place
during the mesenchymal condensation prior to cartilage for-
mation [14]. These results suggest that ChM-I participates in
the formation of an avascular zone in the limb mesoderm and
during the precartilaginous vascular regression.
Interestingly, a high level of ChM-I mRNA was detected in
the upper part of the developing heart at stage 21 (Fig. 4),
while there was no expression of ChM-I mRNA in the heart
Fig. 3. Northern blot analysis of ChM-I mRNA in chick embryos. (A) Alternative utilization of polyadenylation signals. Total RNA was iso-
lated from sterna of day 20 chicken embryos and 20 Wg of RNA was loaded in each lane. Hybridization probes (probe A and probe B) are
shown as shadowed boxes in the bottom panel where the coding region is boxed. All three transcripts (3.3, 2.0 and 1.7 kb in size) were recog-
nized with probe A, while the 3.3 kb transcript was visualized with probe B. (B) Total RNA (20 Wg) was isolated from the indicated tissues of
stage 45 (day 20) chicken embryos and probed with a chicken ChM-I cDNA clone (probe A) and a rat type II collagen cDNA. Equivalent
loading of total RNA was veri¢ed with ethidium bromide staining. The positions of 28S and 18S ribosomal RNA are indicated.
Fig. 4. Whole-mount in situ hybridization of ChM-I mRNA during embryogenesis. The expression of the ChM-I gene was detected in eye,
bronchial arches, heart, somites, limbs and roof plate in the chicken embryo at stage 21. Avascular peripheral mesoderm (*) and atrium and
truncus arteriosus (Q) are denoted. A forelimb at stage 24 is shown in the inset. Cartilaginous condensation (R) at the center of the limb bud
is denoted.
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at stage 45 (Fig. 3B). In chicken, endocardium derived from
splanchnic mesoderm fuses to form a single pumping heart
tube at stage 9 [13]. Around this stage, we could not detect
the expression of ChM-I mRNA in the heart (data not
shown). At stage 18, the heart is a two-chambered tube,
with one atrium and one ventricle [13]. However, at the stage
where the partitioning of the tube into a distinctive atrium
and ventricle occurs, ChM-I is expressed in sinus venosus,
endocardium, truncus arteriosus and atrio-ventricular cushion
(U. Dietz, personal communication, GSF-Research Center,
Munich, Germany). This partitioning of the tube is accom-
plished when cells detach from the endocardium and enter the
hyaluronate-rich ‘cardiac jelly’ to form the endocardial cush-
ion. The present hybridization data suggest an involvement of
ChM-I protein in this process as one of the bioactive compo-
nents in ‘cardiac jelly’. This possibility will be tested by the
immunochemical analysis using anti-chicken ChM-I antibody.
The expression of ChM-I was associated with vascular re-
gression in limb buds as well as avascular tissues such as
cartilage and eye (Fig. 3), indicating its functional role in
angiogenic switching of tissues [7]. Molecular cloning of
chicken ChM-I enabled us to determine its expression pattern
at earlier stages of development (Fig. 4). It is especially intri-
guing to clarify the functional role of ChM-I expressed in
somites, bronchial arches and neural tube at the early devel-
opmental stages prior to establishment of the vascular system
in embryos. Experiments for the generation of ChM-I null
mutant mice are now underway. Moreover, by comparison
of the chicken ChM-I sequence with those of mammalian
counterparts, it was suggested that the N-terminal hydrophilic
domain of ChM-I might be dispensable for its anti-angiogenic
action [6]. Thus, recombinant ChM-I lacking the N-terminal
domain was expressed. Evaluation of its bioactivity is now
underway in vitro and in vivo.
Acknowledgements: We are grateful to Dr U. Dietz and Dr R. Balling
(GSF-Research Center in Munich) for their discussion and communi-
cation of their data prior to publication. We are also indebted to Dr
K. Iyama (Kumamoto University School of Medicine) for his techni-
cal advice. This work was partly supported by the Special Coordina-
tion Funds for Promoting Science and Technology from the Science
and Technology Agency of Japan and the grants-in-aid from the
Ministry of Education, Science and Culture of Japan.
References
[1] Hiraki, Y., Tanaka, H., Inoue, H., Kondo, J., Kamizono, A. and
Suzuki, F. (1991) Biochem. Biophys. Res. Commun. 175, 971^
977.
[2] Inoue, H., Kondo, J., Koike, T., Shukunami, C. and Hiraki, Y.
(1997) Biochem. Biophys. Res. Commun. 241, 395^400.
[3] Mori, Y. et al. (1997) FEBS Lett. 406, 310^314.
[4] Hiraki, Y. et al. (1997) J. Biol. Chem. 272, 32419^32426.
[5] Hiraki, Y., Kono, T., Sato, M., Shukunami, C. and Kondo, J.
(1997) FEBS Lett. 415, 321^324.
[6] Hiraki, Y. et al. (1999) Eur. J. Biochem. 260, 869^878.
[7] Shukunami, C., Iyama, K.-I., Inoue, H. and Hiraki, Y. (1999)
Int. J. Dev. Biol. 43, 39^50.
[8] Shukunami, C. and Hiraki, Y. (1998) Biochem. Biophys. Res.
Commun. 249, 885^890.
[9] Chomczynski, P. and Sacchi, N. (1987) Anal. Biochem. 162, 156^
159.
[10] Hayashi, M., Ninomiya, Y., Parsons, J., Hayashi, K., Olsen,
B.R. and Trelstad, R.L. (1986) J. Cell Biol. 102, 2302^2309.
[11] Hamburger, H. and Hamilton, H. (1951) J. Morphol. 88, 49^
92.
[12] Hiraki, Y., Yutani, Y., Fukuya, M., Takigawa, M. and Suzuki,
F. (1985) Biochem. Int. 10, 267^272.
[13] Gilbert, S.F. (1997) in: Developmental Biology, pp. 358^371,
Sinauer Associates, MA.
[14] Hallmann, R., Feinberg, R.N., Latker, C.H., Sasse, J. and Risau,
W. (1987) Di¡erentiation 34, 98^105.
FEBS 22380 23-7-99 Cyaan Magenta Geel Zwart
C. Shukunami et al./FEBS Letters 456 (1999) 165^170170
